“Sparsentan: Sparsentan- A novel, non- immunosuppressive, dual action angiotensin II and endothelin A receptor antagonist -A new hope for glomerular disease” (2024) Journal of Shaheed Suhrawardy Medical College, 14(2), pp. 58–62. doi:10.3329/jssmc.v14i2.73180.